Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Fineqia International Completes Oversubscribed Private Placement (click to learn more) RVV Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Radient Technologies Inc V.RTI.H

Alternate Symbol(s):  RDDTF

Healthcare Drug Manufacturers - Major Cannabis
Radient Technologies Inc. is a science-based company. The Company is a commercial manufacturer of cannabinoid-based formulations, ingredients, and products. The principal activities of the Company and its subsidiaries are engaged in research, development, and commercialization of an efficient and environmentally responsible technology for the extraction, isolation, and purification of soluble products from a range of materials using microwave technology and a customized hydrocarbon extraction platform. The Company is focused on the formulation, manufacturing and launching of value-added cannabis products. It utilizes a proprietary extraction and downstream processing platform that recovers up to 99% of cannabinoids from the cannabis plant. It develops specialty products and ingredients that contain a range of cannabinoid and terpene profiles.


TSXV:RTI.H - Post by User

Radient Technologies Inc
Bullboard Posts
User Avatar Image
(3)
•••
Comment by gooddogon Apr 03, 2017 3:04pm
119 Views
Post# 26069556

RE:RE:RE:RE:RE:RE:RE:RE:RE:There's a news article up on questrade about marketing

RE:RE:RE:RE:RE:RE:RE:RE:RE:There's a news article up on questrade about marketingRBM, while all this speculating is going on you might want to add that RTI didn't "jump the gun" as it were. They needed a licenced partner to work with, in order to test their process in real time. The Canadian Government doesn't like you to go out and buy 50 kilos or so from your local dealer just to do that!
We know that the first phase of the testing was successful enough to launch the second stage and that should be wrapping up just about now. Thney already know how successful it was or wasn't and I think it was VERY successful.
Also, we know that RTI applied for their own license to produce oil under their own name. If the process is advancing as it should, they (RTI) may have heard that they are entering the inspection phase of the process, which is very good news for applicants.
The announcement of legalization may have added pressure to Health Canada to get more liocences in place and RTI already has a history and is in good standing with the federal government (the RTI process is tied  to federal resaerch)
Options make you money and in an industry that is about to be legalized in a year or so, you need lots of it to stay ahead of the curve.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities